Barely Significant
← all excerpts

Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children.

Neuropsychiatr Dis Treat · 2011 · PMC3191867 · PMID 22003294

1
hedged sentence
closest p
boldest claim

The sentences

highly significantno p-value reported
The author states that “the majority of subjects show improvement in both severity and frequency of drooling while taking glycopyrrolate.” Details of statistical analyses do not include quantitation of improvements though the changes on glycopyrrolate were reported as highly significant for both frequency and severity.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.